Aurobindo Pharma Limited — Others, 14-08-2025: Shareholders meeting

Aurobindo Pharma has announced its 38th Annual General Meeting (AGM) to be held virtually on September 10, 2025, at 3:30 p.m. Shareholders will vote on adopting the audited financial statements for the financial year ended March 31, 2025. The agenda also includes the re-appointment of two directors, Mr. P. Sarath Chandra Reddy and Dr. Satakarni Makkapati, and the appointment of M/s. MRR & Associates as the Secretarial Auditor for five years. This meeting ensures key governance approvals and board continuity. Remote e-voting is available for shareholders.